MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ABT — Abbott Laboratories
NYSEAbbott Laboratories
$96.69
-2.14(-2.17%)
- O
- 99.10
- H
- 99.45
- L
- 96.54
- V
- 8.57M
⏱️ End-of-day dataAs of Oct 1, 2026
ABT — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $680.30M | $852.20M | $751.10M | $695.10M | $653.20M | $761.60M |
| Other Short Term Investments | $49.20M | $41.70M | $22.20M | $33.10M | $31.20M | $35.10M |
| Accounts Receivable | $821.00M | $792.90M | $813.80M | $797.20M | $732.70M | $692.50M |
| Other Receivables | $301.40M | $264.00M | $226.00M | $226.00M | $234.30M | $257.00M |
| Inventory | $698.90M | $648.80M | $670.80M | $695.40M | $663.90M | $619.40M |
| Total Current Assets | $2.55B | $2.60B | $2.48B | $2.45B | $2.32B | $2.37B |
| Accumulated Depreciation | $-1.34B | $-1.34B | $-1.33B | $-1.31B | $-1.25B | $-1.21B |
| Goodwill | $8.83B | $5.36B | $5.35B | $5.38B | $5.30B | $5.29B |
| Intangible Assets | $1.79B | $552.60M | $559.40M | $592.00M | $626.10M | $664.70M |
| Investments And Advances | $109.00M | $91.80M | $95.10M | $95.80M | $90.70M | $88.60M |
| Other Non Current Assets | $1.84B | $1.84B | $1.73B | $1.73B | $1.68B | $1.65B |
| Total Non Current Assets | $8.49B | $6.07B | $5.93B | $5.95B | $5.83B | $5.78B |
| Total Assets | $11.04B | $8.67B | $8.42B | $8.40B | $8.14B | $8.14B |
| Accounts Payable | $467.90M | $424.00M | $412.30M | $430.60M | $421.40M | $419.50M |
| Accrued Expenses | $759.10M | $687.50M | $761.50M | $720.60M | $676.70M | $622.30M |
| Short Term Debt | $440.90M | $303.30M | $134.50M | $50.70M | $50.60M | $150.00M |
| Tax Payable | $59.80M | $56.90M | $46.90M | $39.00M | $48.50M | $59.40M |
| Total Current Liabilities | $1.84B | $1.65B | $1.46B | $1.34B | $1.30B | $1.42B |
| Long Term Debt | $2.96B | $1.08B | $1.16B | $1.29B | $1.27B | $1.35B |
| Other Non Current Liabilities | $971.30M | $253.80M | $673.90M | $680.10M | $664.40M | $344.30M |
| Total Non Current Liabilities | $3.94B | $1.74B | $1.83B | $1.97B | $1.94B | $1.94B |
| Total Liabilities | $5.77B | $3.39B | $3.29B | $3.32B | $3.24B | $3.35B |
| Common Stock | $2.54B | $2.55B | $2.54B | $2.53B | $2.51B | $2.52B |
| Retained Earnings | $5.00B | $4.98B | $4.91B | $4.85B | $4.77B | $4.73B |
| Other Shareholders Equity | $-631.20M | $-600.10M | $-668.40M | $-657.60M | $-741.70M | $-790.60M |
| Total Shareholders Equity | $5.27B | $5.28B | $5.13B | $5.08B | $4.91B | $4.79B |
| Treasury Stock | $1.69B | $1.72B | $1.69B | $1.66B | $1.66B | $1.68B |
| Minority Interest | $64.00M | $64.10M | $31.00M | $26.40M | $25.30M | $23.70M |
| Properties | N/A | $1.76B | N/A | N/A | N/A | $1.55B |
| Land And Improvements | N/A | $54.10M | N/A | N/A | N/A | $52.80M |
| Construction In Progress | N/A | $256.70M | N/A | N/A | N/A | $248.80M |
| Provision For Risks And Charges | N/A | $139.70M | N/A | N/A | N/A | N/A |
| Deferred Liabilities | N/A | $55.90M | N/A | N/A | N/A | $51.20M |